Leerink Partners analyst Mani Foroohar raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $11.00 (from $9.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE